Skip to main content

Home/ Health affairs/ Group items tagged clinical

Rss Feed Group items tagged

pharmacybiz

Mounjaro: New Diabetes Medicine Approved for Weight Loss - 0 views

  •  
    A diabetes medicine, Mounjaro, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat overweight patients. The weight loss medication originally developed for Type 2 diabetes is now accessible to individuals aged 18 and over who are dealing with obesity and weight-related health issues. The active ingredient, tirzepatide, works by making the patient feel fuller and reducing food cravings. The injection helps individuals lose 20 per cent of their body weight, and are advised to follow a reduced-calorie diet and increase physical activity simultaneously. Although it is not authorised to use on the NHS as yet but future approvals can be predicted.
pharmacybiz

Durvalumab can improve life span of lung cancer patients - 0 views

  •  
    The drug, 'durvalumab', can double the overall time someone can survive with an aggressive form of lung cancer from two-and-a-half to five years. It has been approved by the National Institute for Health and Care Excellence (NICE) and the NHS has sealed a deal with manufacturer AstraZeneca to begin rolling it out. The new treatment will be offered to more than 550 patients a year with advanced non-small-cell lung cancer (NSCLC) who have already undergone both chemotherapy and radiotherapy concurrently. NHS said: "The drug can stop the cancer from getting worse for more than two years - significantly longer than treatment with a combination of chemotherapy and radiotherapy, which can only hold the disease at bay for around six months. This increases overall survival time and gives patients more precious moments with their loved ones." Dame Cally Palmer, national cancer director for NHS England, said: "We are resolute in our ambition to fight the devastating effects of cancer and new pioneering treatments like durvalumab are a vital lifeline for people living with cancer - giving them more precious time with family and friends.
aestivaclinic

Male Breast Reduction Cost in Delhi - 1 views

  •  
    Searching for a renowned and skilled male breast reduction surgeon in Delhi to achieve a masculine body? Consult Dr. Mrinalini Sharma at Aestiva Clinic. Male breast reduction emerges as a source of embarrassment for men. It is a surgical procedure for correcting overdeveloped or enlarged male breasts. Male breast reduction entails removing glandular tissues to ensure the enlargement does not reoccur. However, one needs to maintain a healthy lifestyle and avoid fluctuations in weight gain to maintain the procedure's results. To benefit from the procedure, visit www.AestivaClinic.com today!
pharmacybiz

ABPI suspends Novo Nordisk's membership for two years - 0 views

  •  
    The Association of the British Pharmaceutical Industry (ABPI) has suspended the membership of Novo Nordisk for two years due to serious breaches of its Code of Practice. The action was taken by the ABPI Board following an investigation and appeals process conducted by the Prescription Medicines Code of Practice Authority (PMCPA) which found Novo Nordisk to be in breach of the ABPI Code of Practice, including Clause 2 which deals with actions "likely to bring discredit on, or reduce confidence in, the pharmaceutical industry". Having considered the case and requesting a further detailed audit of Novo Nordisk's compliance processes, the ABPI Board decided to suspend Novo Nordisk from ABPI membership. Susan Rienow, President-Elect, ABPI, said: "The ABPI Board has carefully considered the PMCPA's case report into Novo Nordisk and the subsequent audit of their compliance procedures. "The Board expressed significant concern about Novo Nordisk's compliance activities and the very serious issues identified. As a result, the ABPI Board have taken the decision to suspend Novo Nordisk from ABPI membership.
pharmacybiz

Gene therapy to treat rare bleeding disorder - 0 views

  •  
    The European Union's health regulator on Friday said it had recommended granting a conditional marketing authorisation for a gene therapy by Australian drugmaker CSL Ltd and partner uniQure N.V. , to treat haemophilia B, a rare bleeding disorder which is caused by genetic anomalies. About one in 40,000 people are affected by the inherited disorder, caused by a gene mutation that hampers the body's ability to make clotting protein factor IX. If approved, the treatment, branded Hemgenix, will be the first gene therapy in the European Union for the condition that is usually treated by regular injections of factor IX, the European Medicines Agency said. CSL had acquired exclusive global rights to Hemgenix in May last year from uniQure N.V.
pharmacybiz

Pharmacy Contraceptive Service launch postponed early 2023 - 0 views

  •  
    The specification for the Pharmacy Contraceptive Service has been launched for pharmacy contractors to download from the NHSBSA website. However, the service will not start on 11th January 2023, as originally planned, but it is expected to commence in early 2023, revealed the Pharmaceutical Services Negotiating Committee (PSNC). It added: "The exact start date is yet to be agreed, as now the service specification has been published, community pharmacy IT system suppliers need time to develop support for the service, so this is available to contractors from the service commencement date." Commenting on the publication of the service specification, Alastair Buxton, Director of NHS Services, at PSNC said: "When time in their busy professional lives allows, the publication of the service specification ahead of the start of the new service provides contractors and their teams with an opportunity to learn more about it and to consider whether it is something they will have the capacity to provide in due course.
pharmacybiz

Choose Right Healthcare Certification for Your Career Goals - 0 views

  •  
    Choosing the right healthcare certification for your career goals should not be taken lightly. With so many certifications available today, it can feel overwhelming and confusing to decide which one is best suited to your individual needs. Whether you're looking for a promotion at work or want to switch careers, having the correct certification can make all the difference when reaching those goals. Thankfully, with some proper research and advice from experts in the field, you can find the perfect healthcare certification for your career goals - let's dive into how! CONSIDER YOUR CURRENT GOALS AND ASPIRATIONS When choosing a healthcare certification, it's important to consider your current goals and aspirations. Before diving into a program or course, reflect on what you want to get out of the experience - is it increased knowledge and skill set, better job prospects, and advancement opportunities? Even if you aren't currently sure about what type of career you want in healthcare, research different certifications and see which ones would bring you one step closer to achieving those goals. For example, medical coding certification is a must for anyone interested in pursuing a career in medical coding and billing. Think about the best investment of your time and energy, so you can reap the benefits later on down the line. No matter where you're starting from or where you hope to go with your career, there are certifications that provide valuable skills in all areas of healthcare.
pharmacybiz

GSK antibiotic drug to treat uncomplicated UTIs - 0 views

  •  
    British pharmaceutical giant GSK said on Saturday (April 15) its oral antibiotic drug to treat uncomplicated urinary tract infections (uUTI) in female adults and adolescents met the main goals in late-stage trials. The drug, gepotidacin, in phase III trials, met its primary goals of being on a par or better than nitrofurantoin, the current standard of care for the treatment of uUTIs, the company said. GSK plans to submit results of the trials to the United States Food and Drug Administration for review later in the second quarter. The drug, if approved, could become the first new type of antibiotic, which is critically important for countering drug-resistant infections, to treat uUTIs in 20 years, the company said. "Gepotidacin, if approved, will offer a much-needed additional oral treatment option for patients at risk of treatment failure associated with resistance or recurrence of uUTI," Chris Corsico, senior vice president of development at GSK, said.
sbaesthetic

Best Plastic Surgeon in Delhi - 1 views

  •  
    Dr. Shilpi Bhadani is a highly respected medical professional, and is known for her expertise in aesthetic and cosmetic surgery of the face and body. She is recognised as the best plastic surgeon in Delhi uses a pragmatic approach in her work and gives her patients the best results. At her facility, SB Aesthetics, she offers specialized plastic and cosmetic surgeries like facial surgeries, body contouring procedures like liposuction & tummy tuck surgery, breast surgeries like breast lift, breast reduction and breast enlargement, hair loss treatments, laser therapies for skin rejuvenation and hair removal, and anti-aging procedures like fillers and facelift. To fetch the benefits of these life changing treatments, visit the clinic today.
pharmacybiz

Revolutionizing Parkinson's Care: Produodopa's Pill-Free Solution - 0 views

  •  
    Many people with advanced Parkinson's disease are currently required to take more than 20 pills a day to manage their symptoms, while some necessitate treatment through a permanent feeding tube. Soon, patients will only be required to wear a portable kit to get a continuous dose of the medication delivered into their bloodstream 24 hours a day. This innovative treatment, called Produodopa, will now be made available on the NHS, providing benefit to nearly 1,000 people with advanced Parkinson's disease, according to a BBC report. James Palmer, NHS England's medical director for specialised services, told the publication that the drug's rollout will offer "a vital new option on the NHS for those who aren't suitable for other treatments such as deep brain stimulation." He added that the new therapy will help patients manage their symptoms "more effectively" and improve their quality of life.
« First ‹ Previous 281 - 290 of 290
Showing 20 items per page